Azamian Bobak R. — SEC insider filings

SEC reporting owner CIK 1827672. 66 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers the 50 most recent of 66 filings on record, filed 2022-11-14 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tarsus Pharmaceuticals, Inc. (TARS)President/CEO and Board Chair, Director50—63 legs · 469,686 sh · $14,399,57823

Insider filings — Azamian Bobak R.

FiledFormIssuerReported transactionsSource
2026-11-174Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 10,000 @ $80.31EDGAR
2026-09-094Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 7,100 @ $90.27 · Sale (S): 2,900 @ $91.27EDGAR
2026-09-034Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 10,000 @ $80.06EDGAR
2026-06-224Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 4,582 @ $61.24 · Sale (S): 5,418 @ $61.81EDGAR
2026-03-194Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 10,972 @ $69.42 · Sale (S): 11,667 @ $68.71 · Sale (S): 11,964 @ $67EDGAR
2026-03-174Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 66,274 · Option exercise (M): 11,300 (derivative) @ $0 · Option exercise (M): 16,975 (derivative) @ $0 · Option exercise (M): 23,121 (derivative) @ $0 · Option exercise (M): 14,878 (derivative) @ $0EDGAR
2026-03-094Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 96,723 (derivative) @ $0 · Grant/award (A): 60,776 (derivative) @ $0EDGAR
2025-12-304Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 5,443 @ $82.41 · Sale (S): 557 @ $83.54EDGAR
2025-12-084Tarsus Pharmaceuticals, Inc. (TARS)Gift (G): 51,885 @ $0EDGAR
2025-09-264Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 6,000 @ $55.37EDGAR
2025-08-134Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 6,000 @ $50EDGAR
2025-03-264Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 6,000 @ $50EDGAR
2025-03-204Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 7,131 @ $46.29 · Sale (S): 8,551 @ $47.40 · Sale (S): 8,534 @ $50.11EDGAR
2025-03-184Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 51,395 · Option exercise (M): 11,299 (derivative) @ $0 · Option exercise (M): 16,975 (derivative) @ $0 · Option exercise (M): 23,121 (derivative) @ $0EDGAR
2025-03-074Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 90,736 (derivative) @ $0 · Grant/award (A): 59,512 (derivative) @ $0EDGAR
2024-03-194Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 28,274 · Sale (S): 10,415 @ $30.60 · Option exercise (M): 11,299 (derivative) @ $0 · Option exercise (M): 16,975 (derivative) @ $0EDGAR
2024-03-114Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 136,947 (derivative) @ $0 · Grant/award (A): 92,485 (derivative) @ $0EDGAR
2023-12-294Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $20.22EDGAR
2023-12-224Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 9,443 @ $19.96 · Sale (S): 30,557 @ $20.36EDGAR
2023-11-174Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 2,896 @ $18.01 · Sale (S): 4,904 @ $18.54 · Sale (S): 200 @ $19.28EDGAR
2023-10-204Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $13.24EDGAR
2023-09-224Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $17.21EDGAR
2023-08-254Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $17.23EDGAR
2023-07-214Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 4,174 @ $19.28 · Sale (S): 99,726 @ $20.04EDGAR
2023-07-144Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 9,000 @ $17.35EDGAR
2023-06-234Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $18.63EDGAR
2023-06-164Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 9,000 @ $18.58EDGAR
2023-06-124Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 3,100 @ $20.01EDGAR
2023-05-194Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $15.90EDGAR
2023-05-124Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 9,000 @ $16.80EDGAR
2023-05-024Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 4,278 @ $15.13 · Sale (S): 5,841 @ $15.10EDGAR
2023-04-254Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 2,311 @ $15.03EDGAR
2023-04-214Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $13.60EDGAR
2023-03-234Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 679 @ $12.89 · Sale (S): 709 @ $12.64 · Sale (S): 737 @ $12.15EDGAR
2023-03-214Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 795 @ $13.28 · Sale (S): 741 @ $12.61EDGAR
2023-03-174Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $13.79 · Option exercise (M): 11,299 · Sale (S): 791 @ $13.43 · Option exercise (M): 11,299 (derivative) @ $0EDGAR
2023-03-104Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 100,242 (derivative) @ $0 · Grant/award (A): 67,900 (derivative) @ $0EDGAR
2023-03-104Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 4,853 @ $15.02 · Sale (S): 717 @ $15.01EDGAR
2023-02-174Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $15.28EDGAR
2023-02-104Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 9,000 @ $15.14EDGAR
2023-01-254Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 4,856 @ $15.45EDGAR
2023-01-244Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 411 @ $15EDGAR
2023-01-204Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $14.56 · Sale (S): 240 @ $15EDGAR
2023-01-134Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 3,904 @ $15.11EDGAR
2023-01-114Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 729 @ $15.15 · Sale (S): 905 @ $15.17EDGAR
2022-12-224Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 8,000 @ $14.57EDGAR
2022-12-204Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 535 @ $15.01EDGAR
2022-12-164Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 6,420 @ $15.08EDGAR
2022-11-184Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 7,255 @ $16.81 · Sale (S): 745 @ $17.31EDGAR
2022-11-144Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 9,000 @ $17.87EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1827672 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs